When I first started the process of unifying our design system, I remember being more overwhelmed than I’d ever felt in my career. This work was unlike any other process I had undertaken before. I wasn’t even clear on what the end goal needed to be…a three-tiered tokenization structure with… Read More
#3 – Ira Hoffman from HighRes In this episode of Designing Open Science, we speak with the CEO of HighRes about building scalable, automated labs that accelerate discovery. We discuss how thoughtful lab design, partnerships, and infrastructure choices are shaping the future of modern research. Ira… Read More
#2 – Curtis Walton In this episode of Designing Open Science, we talk with the Director of Automation at the Institute of Protein Innovation about building automation that truly supports scientists at the bench. We explore how scalable, flexible lab systems improve reproducibility, collaboration, and access—and… Read More
#1 – Introduction Welcome to the Designing Open Science Podcast, a new podcast from Opentrons about building the future of science featuring the people shaping its tools, workflows, and ideas, Hosted by Kinnari Watson, PhD. In each episode, we’ll feature conversations with scientists, partners, and industry… Read More
Opentrons integrates NVIDIA Isaac and NVIDIA Cosmos physical AI software with Opentrons’ global network of 10,000 laboratory robots to enable AI systems that learn from real-world biological experimentation NEW YORK, February 5, 2026 – Opentrons Labworks Inc., a laboratory robotics company enabling AI driven autonomous science, is accelerating the development… Read More
Joint collaboration unites powerful robotics with AI-driven orchestration to redefine how labs scale automation BEVERLY, MA and NEW YORK (February 4, 2026) — HighRes, Inc., a leader in laboratory automation and orchestration software, and Opentrons Labworks, Inc., the leading laboratory robotics company building the physical infrastructure for AI-driven autonomous science,… Read More
Opentrons Robotics Network Infrastructure Becoming Core for AI-Driven Drug Discovery NEW YORK, January 29, 2026 — Opentrons Labworks, Inc., a laboratory robotics company building the physical infrastructure for AI-driven drug discovery, today announced the promotion of James Atwood to Chief Executive Officer. Atwood assumed the role of CEO in… Read More
GlobalBio’s validated, highly diverse human antibody libraries are now available pre-integrated into Neochromosome’s novel neoSwitch™ yeast strain, enabling rapid in-house antibody discovery via yeast display and streamlined lead characterization in secretion mode. LONG ISLAND CITY, N.Y. AND CAMBRIDGE, MA – November 12, 2025 – Neochromosome, Inc., the genome-scale cell engineering… Read More
With the iGEM Grand Jamboree kicking off this week, we are proud to spotlight three of our 2025 Opentrons-sponsored iGEM teams presenting in Paris this week, each tackling ambitious global challenges with creativity, collaboration, and open science. Learn more about these incredible projects below! iGEM Lambert Project Name: LANCET… Read More
